Table:
| (Dollars in Millions) | April 28, 2018 | April 29, 2017 | Net Change ($) | Net Change (%) |
| --- | --- | --- | --- | --- |
| Net Sales | $ 0.3 | $ 0.2 | $ 0.1 | 50.0 % |
| Gross Profit | $ (3.5) | $ (3.1) | $ (0.4) | (12.9)% |
| Loss from Operations | $ (11.4) | $ (8.5) | $ (2.9) | (34.1)% |
Paragraphs:
Medical Segment Results
Below is a table summarizing results for the fiscal years ended:
Net Sales. The Medical segment had minimal net sales in both periods from newly launched products.
Gross Profit. Medical segment gross profit was a loss of $3.5 million in fiscal 2018 compared to a loss of $3.1 million in fiscal 2017. The increased loss primarily relates to the vertical manufacturing integration of some key components and research efforts to expand the product offerings.
Loss from Operations. Medical segment loss from operations increased $2.9 million to $11.4 million in fiscal 2018 compared to $8.5 million in fiscal 2017. The increased loss relates to higher outside professional fees, research and development and marketing expenses in fiscal 2018. Financial Condition, Liquidity and Capital Resources
Question:
How much was the Medical segment gross profit in fiscal 2018 and 2017 respectively?